نتائج البحث - "Eric W. Humke"

1

دورية أكاديمية

Gli Protein Activity Is Controlled by Multisite Phosphorylation in Vertebrate Hedgehog Signaling

المؤلفون: Pawel Niewiadomski, Jennifer H. Kong, Robert Ahrends, Yan Ma, Eric W. Humke, Sohini Khan, Mary N. Teruel, Bennett G. Novitch, Rajat Rohatgi

المصدر: Cell Reports, Vol 6, Iss 1, Pp 168-181 (2014)

مصطلحات موضوعية: Biology (General), QH301-705.5

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S221112471300733XTest; https://doaj.org/toc/2211-1247Test

الوصول الحر: https://doaj.org/article/6a63a339a9c3497cb6b345fdd65039d4Test

View record in DOAJ

النص الكامل

2

Supplementary Figure 1 from Phase Ia Study of Anti-NaPi2b Antibody–Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non–Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38becf22c0cb4090fc7526cc5dc5f7b1Test
https://doi.org/10.1158/1078-0432.22474400.v1Test

3

Data from Phase Ia Study of Anti-NaPi2b Antibody–Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non–Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dcfaf1467d4088929a6f4be22f3b838Test
https://doi.org/10.1158/1078-0432.c.6528776.v1Test

4

Supplementary Figure 2 from Phase Ia Study of Anti-NaPi2b Antibody–Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non–Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f4792574451e294405cc4ee7c39e46fTest
https://doi.org/10.1158/1078-0432.22474397Test

5

Supplementary Tables from Phase Ia Study of Anti-NaPi2b Antibody–Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non–Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e868350c55d17cd24a597cdfc33a2e3Test
https://doi.org/10.1158/1078-0432.22474394.v1Test

6

Abstract 6123: Characterization of the synergistic tumor cytotoxicity of agonistic DR5 IgM antibody IGM-8444 with chemotherapeutic agents

المؤلفون: Beatrice T. Wang, Thomas J. Matthew, Poonam Yakkundi, Miho Oyasu, Mélanie Desbois, Susan E. Calhoun, Ling Wang, Tasnim Kothambawala, Devinder K. Ubhi, Marvin S. Peterson, Eric W. Humke, Maya F. Kotturi, Bruce A. Keyt, Angus M. Sinclair

المصدر: Cancer Research. 83:6123-6123

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b373a6e5565ab111602fae6805a131b0Test
https://doi.org/10.1158/1538-7445.am2023-6123Test

7

Abstract P2-11-05: ER pathway activity signature as a biomarker for endocrine agent GDC-9545

المصدر: Cancer Research. 80:P2-11

مصطلحات موضوعية: Cancer Research, Oncology, business.industry, Cancer research, Biomarker (medicine), Endocrine system, Medicine, business, Pathway activity

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3ddcf33497fd7512a8f5fb8ca97e4d87Test
https://doi.org/10.1158/1538-7445.sabcs19-p2-11-05Test

8

Abstract P5-11-07: Real-world predictors of first-line treatment and descriptive outcomes in HR+/HER2− metastatic breast cancer patients in the US

المؤلفون: Patricia Luhn, Sherene Loi, Mary K Downer, Eric W. Humke, Aditya Bardia, Matthew Kent, Komal Jhaveri

المصدر: Cancer Research. 80:P5-11

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Confounding, Cancer, Odds ratio, Palbociclib, medicine.disease, Metastatic breast cancer, Confidence interval, law.invention, Breast cancer, Randomized controlled trial, law, Internal medicine, medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5ae8ff80654c34faaf94997f34df3d6bTest
https://doi.org/10.1158/1538-7445.sabcs19-p5-11-07Test

9

Phase Ia Study of Anti-NaPi2b Antibody–Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non–Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer

المصدر: Clinical Cancer Research. 26:364-372

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Antibody-drug conjugate, Immunoconjugates, Lung Neoplasms, Maximum Tolerated Dose, Organoplatinum Compounds, Nausea, Carcinoma, Ovarian Epithelial, Neutropenia, Antibodies, Monoclonal, Humanized, Sodium-Phosphate Cotransporter Proteins, Type IIb, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Pharmacokinetics, Carcinoma, Non-Small-Cell Lung, Internal medicine, Biomarkers, Tumor, medicine, Humans, Tissue Distribution, Lung cancer, Aged, Aged, 80 and over, business.industry, Middle Aged, medicine.disease, Treatment Outcome, 030104 developmental biology, Oncology, Monomethyl auristatin E, chemistry, Tolerability, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Vomiting, Female, Patient Safety, medicine.symptom, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bffb8efc8059c3c0921e2c309dbf390Test
https://doi.org/10.1158/1078-0432.ccr-18-3965Test

10

An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer

المؤلفون: Lisa Barroilhet, Martin Gutierrez, Howard A. Burris, Voleak Choeurng, Stephanie Royer-Joo, Anjali Vaze, Yulei Wang, Kathleen N. Moore, Eric W. Humke, Judy S. Wang, Renee Commerford, Joyce F. Liu

المصدر: Gynecologic oncology. 163(3)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8be700103031bde3b3fe4670a0c3f146Test
https://pubmed.ncbi.nlm.nih.gov/34627611Test

تنقيح النتائج